Cypress Capital Management (Wyoming)’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-9,976
Closed -$2.73M 245
2020
Q3
$2.73M Sell
9,976
-79
-0.8% -$22.8K 2.45% 8
2020
Q2
$2.43M Sell
10,055
-361
-3% -$72.5K 2.43% 9
2020
Q1
$1.51M Sell
10,416
-1,105
-10% -$183K 2.13% 17
2019
Q4
$1.97M Buy
+11,521
New +$2.14M 1.85% 20
2019
Q2
Sell
-62
Closed -$18K 295
2019
Q1
$18K Sell
62
-63
-50% -$20.9K 0.02% 157
2018
Q4
$41K Sell
125
-95
-43% -$33K 0.08% 137
2018
Q3
$99K Hold
220
0.1% 124
2018
Q2
$90K Buy
220
+170
+340% +$61.6K 0.09% 123
2018
Q1
$15K Buy
+50
New +$12.7K 0.02% 226
2017
Q1
Sell
-1,110
Closed -$126K 292
2016
Q4
$126K Buy
1,110
+40
+4% +$4.63K 0.13% 85
2016
Q3
$138K Buy
1,070
+100
+10% +$12K 0.18% 77
2016
Q2
$106K Buy
970
+535
+123% +$53.2K 0.14% 74
2016
Q1
$41.2K Buy
+435
New +$36.7K 0.06% 113

Other funds holding ABMD

Cypress Capital Management (Wyoming)'s ABMD Position: Q4 2020 in Review

Cypress Capital Management (Wyoming) sold out of Abiomed Inc (ABMD) in Q4 2020, closing a stake of 9,976 shares — an estimated $2.73M sold.

Cypress Capital Management (Wyoming) first reported a position in ABMD in Q1 2016 and held it in 13 quarters. The position peaked at $2.73M in Q3 2020. 498 funds tracked by Wall St. Rank hold ABMD as of Q4 2020.

  • Cypress Capital Management (Wyoming) reported no remaining Abiomed Inc position as of Q4 2020 after selling out during the quarter.
  • Cypress Capital Management (Wyoming) sold 9,976 Abiomed Inc shares in Q4 2020, an estimated $2.73M.
  • Cypress Capital Management (Wyoming) first reported a position in Abiomed Inc in Q1 2016 and held it in 13 quarters.
  • Cypress Capital Management (Wyoming)'s Abiomed Inc position peaked at $2.73M in Q3 2020.
  • 498 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2020.

Based on Cypress Capital Management (Wyoming)'s 13F filing for Q4 2020, filed 29 Jan 2021.